When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus.
暂无分享,去创建一个
Á. Soriano | R. Kuehl | S. Meylan | J. Mensa | L. Morata
[1] A. Richardson,et al. The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection , 2019, mBio.
[2] B. Conlon,et al. Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus. , 2019, Cell chemical biology.
[3] T. Coenye,et al. Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms. , 2019, Trends in microbiology.
[4] J. Adkins,et al. Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells , 2019, mBio.
[5] A. Peleg,et al. Unstable chromosome rearrangements in Staphylococcus aureus cause phenotype switching associated with persistent infections , 2019, Proceedings of the National Academy of Sciences.
[6] Charlotte Michaux,et al. Bacterial Persisters and Infection: Past, Present, and Progressing. , 2019, Annual review of microbiology.
[7] O. Melter,et al. Evaluation of TD test for analysis of persistence or tolerance in clinical isolates of Staphylococcus aureus , 2019 .
[8] Petia M. Vlahovska,et al. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus , 2019, Proceedings of the National Academy of Sciences.
[9] J. Collins,et al. Definitions and guidelines for research on antibiotic persistence , 2019, Nature Reviews Microbiology.
[10] S. Hultgren,et al. The Widely Used Antimicrobial Triclosan Induces High Levels of Antibiotic Tolerance In Vitro and Reduces Antibiotic Efficacy up to 100-Fold In Vivo , 2019, Antimicrobial Agents and Chemotherapy.
[11] A. Charbit,et al. Chronic Staphylococcus aureus lung infection correlates with proteogenomic and metabolic adaptations leading to an increased intracellular persistence , 2018, bioRxiv.
[12] Jonathan M Stokes,et al. Bacterial Metabolism and Antibiotic Efficacy , 2019, Cell metabolism.
[13] A. Saliba,et al. Salmonella persisters undermine host immune defenses during antibiotic treatment , 2018, Science.
[14] T. Kirikae,et al. Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS) , 2018, Antimicrobial Agents and Chemotherapy.
[15] Melissa J. Martin,et al. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus dsp1 and asp23 , 2018, Antimicrobial Agents and Chemotherapy.
[16] L. Cegelski,et al. A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells. , 2018, Journal of the American Chemical Society.
[17] Nadja Leimer,et al. Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters , 2018, Nature Communications.
[18] Liang Li,et al. Role of Purine Biosynthesis in Persistent Methicillin-Resistant Staphylococcus aureus Infection , 2018, The Journal of infectious diseases.
[19] B. Pozzetto,et al. Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization , 2018, The Journal of antimicrobial chemotherapy.
[20] Pia Abel zur Wiesch,et al. Estimating treatment prolongation for persistent infections , 2018, Pathogens and disease.
[21] R. Proctor,et al. Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA , 2018, The Journal of antimicrobial chemotherapy.
[22] C. Wolz,et al. Inactivation of TCA cycle enhances Staphylococcus aureus persister cell formation in stationary phase , 2018, Scientific Reports.
[23] A. Tomasz,et al. Phenotypic signatures and genetic determinants of oxacillin tolerance in a laboratory mutant of Staphylococcus aureus , 2018, PloS one.
[24] M. Fontaine‐Aupart,et al. Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections , 2018, The Journal of antimicrobial chemotherapy.
[25] S. Lévêque-Fort,et al. Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus , 2018, Antimicrobial Agents and Chemotherapy.
[26] M. Fauvart,et al. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[27] S. Pederson,et al. Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes , 2018, mBio.
[28] S. Kundu,et al. Functionalization of β-lactam antibiotic on lysozyme capped gold nanoclusters retrogress MRSA and its persisters following awakening , 2018, Scientific Reports.
[29] JianHe Sun,et al. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice , 2018, Applied and Environmental Microbiology.
[30] Huajian Gao,et al. A new class of synthetic retinoid antibiotics effective against bacterial persisters , 2018, Nature.
[31] J. Collins,et al. Targeting Antibiotic Tolerance, Pathogen by Pathogen , 2018, Cell.
[32] P. Garred,et al. Persistent Intracellular Staphylococcus aureus in Keratinocytes Lead to Activation of the Complement System with Subsequent Reduction in the Intracellular Bacterial Load , 2018, Front. Immunol..
[33] M. Vestergaard,et al. Quorum Sensing-Regulated Phenol-Soluble Modulins Limit Persister Cell Populations in Staphylococcus aureus , 2018, Front. Microbiol..
[34] J. Diallo,et al. Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms , 2018, Front. Microbiol..
[35] D. Robinson,et al. Mutation of Agr Is Associated with the Adaptation of Staphylococcus aureus to the Host during Chronic Osteomyelitis , 2018, Front. Cell. Infect. Microbiol..
[36] J. Drijfhout,et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms , 2018, Science Translational Medicine.
[37] R. Montelaro,et al. Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2 , 2017, Scientific Reports.
[38] M. Fauvart,et al. Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models , 2017, Front. Microbiol..
[39] Saloni R. Jain,et al. Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics. , 2017, Molecular cell.
[40] M. Elasri,et al. msaABCR operon is involved in persister cell formation in Staphylococcus aureus , 2017, BMC Microbiology.
[41] G. Aisenberg,et al. Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] Y. Zhang,et al. The Agr Quorum Sensing System Represses Persister Formation through Regulation of Phenol Soluble Modulins in Staphylococcus aureus , 2017, Front. Microbiol..
[43] K. Drlica,et al. Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by Staphylococcus aureus , 2017, mBio.
[44] Matthias Heinemann,et al. Bacterial persistence from a system-level perspective. , 2017, Current opinion in biotechnology.
[45] L. Good,et al. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections , 2017, British journal of pharmacology.
[46] N. Shoresh,et al. An Experimental Framework for Quantifying Bacterial Tolerance , 2017, Biophysical journal.
[47] M. Wittekind,et al. Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent , 2017, Antimicrobial Agents and Chemotherapy.
[48] M. Seleem,et al. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate. , 2017, Biochimica et biophysica acta. General subjects.
[49] Hussain Yousaf,et al. Identification of N‐Arylated NH125 Analogues as Rapid Eradicating Agents against MRSA Persister Cells and Potent Biofilm Killers of Gram‐Positive Pathogens , 2017, Chembiochem : a European journal of chemical biology.
[50] K. Lewis,et al. ATP-Dependent Persister Formation in Escherichia coli , 2017, mBio.
[51] N. Balaban,et al. TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay , 2017, Scientific Reports.
[52] T. Shireman,et al. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia , 2017, The Journal of antimicrobial chemotherapy.
[53] G. Schultz,et al. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria. , 2017, International journal of antimicrobial agents.
[54] K. Gerdes,et al. Mechanisms of bacterial persistence during stress and antibiotic exposure , 2016, Science.
[55] T. Wood,et al. Halogenated indoles eradicate bacterial persister cells and biofilms , 2016, AMB Express.
[56] N. Cogan,et al. Theoretical and experimental evidence for eliminating persister bacteria by manipulating killing timing. , 2016, FEMS microbiology letters.
[57] K. Hiramatsu,et al. In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin , 2016, Antimicrobial Agents and Chemotherapy.
[58] Thomas B. Clarke,et al. Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids , 2016, Nature Microbiology.
[59] T. Wood,et al. DNA‐crosslinker cisplatin eradicates bacterial persister cells , 2016, Biotechnology and bioengineering.
[60] M. Seleem,et al. Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide. , 2016, Journal of the American Chemical Society.
[61] P. Stewart,et al. Gel-Entrapped Staphylococcus aureus Bacteria as Models of Biofilm Infection Exhibit Growth in Dense Aggregates, Oxygen Limitation, Antibiotic Tolerance, and Heterogeneous Gene Expression , 2016, Antimicrobial Agents and Chemotherapy.
[62] A. Cheung,et al. Effect of clpP and clpC deletion on persister cell number in Staphylococcus aureus. , 2016, Journal of medical microbiology.
[63] J. O’Gara,et al. Untangling the Diverse and Redundant Mechanisms of Staphylococcus aureus Biofilm Formation , 2016, PLoS pathogens.
[64] P. Kubes,et al. Br Ief Definitive Repor T Identification and Treatment of the Staphylococcus Aureus Reservoir in Vivo , 2022 .
[65] M. Fauvart,et al. Should we develop screens for multi-drug antibiotic tolerance? , 2016, Expert review of anti-infective therapy.
[66] N. Verstraeten,et al. In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens , 2016, Antimicrobial Agents and Chemotherapy.
[67] Ofer Fridman,et al. Distinguishing between resistance, tolerance and persistence to antibiotic treatment , 2016, Nature Reviews Microbiology.
[68] M. Prax,et al. Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters , 2016, PloS one.
[69] Pieterjan Vanden Boer,et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence , 2016, Nature Microbiology.
[70] A. Gründling,et al. ppGpp negatively impacts ribosome assembly affecting growth and antimicrobial tolerance in Gram-positive bacteria , 2016, Proceedings of the National Academy of Sciences.
[71] Petia M. Vlahovska,et al. NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption. , 2016, Future medicinal chemistry.
[72] P. François,et al. Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon , 2016, Antimicrobial Agents and Chemotherapy.
[73] Nadja Leimer,et al. Nonstable Staphylococcus aureus Small-Colony Variants Are Induced by Low pH and Sensitized to Antimicrobial Therapy by Phagolysosomal Alkalinization. , 2016, The Journal of infectious diseases.
[74] W. Xiong,et al. Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study) , 2015, BMC Infectious Diseases.
[75] J. Adkins,et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. , 2016, Nature microbiology.
[76] V. Fowler,et al. Infective endocarditis , 2016, Nature Reviews Disease Primers.
[77] J. Zhao,et al. Transposon Mutagenesis Identifies Novel Genes Associated with Staphylococcus aureus Persister Formation , 2015, Frontiers in Microbiology.
[78] J. Haldar,et al. Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection , 2015, PloS one.
[79] M. Vestergaard,et al. Activation of the SOS response increases the frequency of small colony variants , 2015, BMC Research Notes.
[80] W. Shi,et al. Genetic Screen Reveals the Role of Purine Metabolism in Staphylococcus aureus Persistence to Rifampicin , 2015, Antibiotics.
[81] P. S. Andersen,et al. Novel antibody–antibiotic conjugate eliminates intracellular S. aureus , 2015, Nature.
[82] T. Wood,et al. Combatting bacterial infections by killing persister cells with mitomycin C. , 2015, Environmental microbiology.
[83] V. Mai,et al. Halogenated Phenazines that Potently Eradicate Biofilms, MRSA Persister Cells in Non-Biofilm Cultures, and Mycobacterium tuberculosis. , 2015, Angewandte Chemie.
[84] Xinmiao Fu,et al. Hypoionic shock treatment enables aminoglycosides antibiotics to eradicate bacterial persisters , 2015, Scientific Reports.
[85] K. Kirker,et al. Potency and penetration of telavancin in staphylococcal biofilms. , 2015, International journal of antimicrobial agents.
[86] B. Zhu,et al. A Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus Persisters , 2015, Antibiotics.
[87] Ahmad S. Khalil,et al. Antibiotic efficacy is linked to bacterial cellular respiration. , 2015, Proceedings of the National Academy of Sciences of the United States of America.
[88] M. Fraunholz,et al. A Novel Point Mutation Promotes Growth Phase-Dependent Daptomycin Tolerance in Staphylococcus aureus , 2015, Antimicrobial Agents and Chemotherapy.
[89] Annie L. Conery,et al. Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy , 2015, PloS one.
[90] Vance G. Fowler,et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.
[91] M. Waldor,et al. Classic reaction kinetics can explain complex patterns of antibiotic action , 2015, Science Translational Medicine.
[92] R. Bertram,et al. The MazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus aureus , 2015, PloS one.
[93] Anthony C. Duong,et al. Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid , 2015, Infection and Immunity.
[94] E. O. López-Villegas,et al. Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening , 2015, PloS one.
[95] J. Parkhill,et al. Staphylococcus aureus Adapts to Oxidative Stress by Producing H2O2-Resistant Small-Colony Variants via the SOS Response , 2015, Infection and Immunity.
[96] J. Parvizi,et al. Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. , 2015, The Journal of infectious diseases.
[97] J. Parvizi,et al. Staphylococcal Persistence Due to Biofilm Formation in Synovial Fluid Containing Prophylactic Cefazolin , 2015, Antimicrobial Agents and Chemotherapy.
[98] Stanley N Cohen,et al. Reversible Antibiotic Tolerance Induced in Staphylococcus aureus by Concurrent Drug Exposure , 2015, mBio.
[99] M. Mariconda,et al. Factors related to outcome of early and delayed prosthetic joint infections. , 2015, The Journal of infection.
[100] P. Stewart. Antimicrobial Tolerance in Biofilms , 2015, Microbiology spectrum.
[101] S. Wigneshweraraj,et al. What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia? , 2014, Trends in microbiology.
[102] W. Eisenreich,et al. Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin. , 2014, International journal of medical microbiology : IJMM.
[103] D. Lebeaux,et al. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. , 2014, The Journal of infectious diseases.
[104] B. Conlon,et al. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[105] N. Shoresh,et al. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations , 2014, Nature.
[106] B. Martínez,et al. Effective Removal of Staphylococcal Biofilms by the Endolysin LysH5 , 2014, PloS one.
[107] Andrea M. Kasko,et al. Engineering Persister-Specific Antibiotics with Synergistic Antimicrobial Functions , 2014, ACS nano.
[108] R. Proctor,et al. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections , 2014, Front. Cell. Infect. Microbiol..
[109] C. Murray,et al. Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro , 2014, BMC Research Notes.
[110] D. Hess,et al. Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. , 2014, Journal of medical microbiology.
[111] A. Singer,et al. Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. , 2014, The New England journal of medicine.
[112] G. Peters,et al. Staphylococcus aureus persistence in non-professional phagocytes. , 2014, International journal of medical microbiology : IJMM.
[113] U. Gerth,et al. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. , 2014, International journal of medical microbiology : IJMM.
[114] T. S. Wilkinson,et al. Dormant Cells of Staphylococcus aureus Are Resuscitated by Spent Culture Supernatant , 2014, PLoS ONE.
[115] C. Wolz,et al. Two Small (p)ppGpp Synthases in Staphylococcus aureus Mediate Tolerance against Cell Envelope Stress Conditions , 2013, Journal of bacteriology.
[116] J. Chapman,et al. Spinal epidural abscesses: risk factors, medical versus surgical management, a retrospective review of 128 cases. , 2013, The spine journal : official journal of the North American Spine Society.
[117] Richard D. Smith,et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection , 2013, Nature.
[118] A. Rincé,et al. Analysis of the tolerance of pathogenic enterococci and Staphylococcus aureus to cell wall active antibiotics. , 2013, The Journal of antimicrobial chemotherapy.
[119] Y. Mizunoe,et al. Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus Biofilm , 2013, Antimicrobial Agents and Chemotherapy.
[120] G. Donelli,et al. Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. , 2013, The Journal of antimicrobial chemotherapy.
[121] R. Proctor,et al. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. , 2013, The Journal of antimicrobial chemotherapy.
[122] E. Gómez-Barrena,et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. , 2013, International journal of antimicrobial agents.
[123] S. Choi,et al. Persistent Staphylococcus aureus Bacteremia , 2013, Medicine.
[124] S. Klumpp,et al. Interplay between Population Dynamics and Drug Tolerance of Staphylococcus aureus Persister Cells , 2013, Journal of Molecular Microbiology and Biotechnology.
[125] H. Park,et al. Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study , 2012, Antimicrobial Agents and Chemotherapy.
[126] P. François,et al. The Stringent Response of Staphylococcus aureus and Its Impact on Survival after Phagocytosis through the Induction of Intracellular PSMs Expression , 2012, PLoS pathogens.
[127] R. Bertram,et al. Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics , 2012, Journal of Molecular Microbiology and Biotechnology.
[128] A. Horswill,et al. Low Levels of β-Lactam Antibiotics Induce Extracellular DNA Release and Biofilm Formation in Staphylococcus aureus , 2012, mBio.
[129] H. Ingmer,et al. Planktonic Aggregates of Staphylococcus aureus Protect against Common Antibiotics , 2012, PloS one.
[130] W. Rose,et al. Vancomycin Tolerance in Methicillin-Resistant Staphylococcus aureus: Influence of Vancomycin, Daptomycin, and Telavancin on Differential Resistance Gene Expression , 2012, Antimicrobial Agents and Chemotherapy.
[131] M. Fraunholz,et al. Intracellular staphylococcus aureus: Live-in and let die , 2012, Front. Cell. Inf. Microbio..
[132] S. V. van Hal,et al. Predictors of Mortality in Staphylococcus aureus Bacteremia , 2012, Clinical Microbiology Reviews.
[133] T. Kielian,et al. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity , 2012, Front. Cell. Inf. Microbio..
[134] A. O’Neill,et al. Loss of Function of the GdpP Protein Leads to Joint β-Lactam/Glycopeptide Tolerance in Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.
[135] James C. Abbott,et al. c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress , 2011, PLoS pathogens.
[136] L. Armitige,et al. Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin , 2011, Journal of Clinical Microbiology.
[137] F. Baldelli,et al. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: Looking for a relationship between tolerance and outcome , 2011, Annals of Clinical Microbiology and Antimicrobials.
[138] James J. Collins,et al. Metabolite-Enabled Eradication of Bacterial Persisters by Aminoglycosides , 2011, Nature.
[139] D. Missiakas,et al. A play in four acts: Staphylococcus aureus abscess formation. , 2011, Trends in microbiology.
[140] V. Gant,et al. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? , 2011, Nature Reviews Microbiology.
[141] H. Ishikura,et al. Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia , 2011, Antimicrobial Agents and Chemotherapy.
[142] R. Proctor,et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection , 2011, EMBO molecular medicine.
[143] P. Miller,et al. Emerging trends in antibacterial discovery : answering the call to arms , 2011 .
[144] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[145] C. Cabellos,et al. Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[146] D. Viemann,et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. , 2010, The Journal of infectious diseases.
[147] Hila Sheftel,et al. Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes , 2010, Nature Methods.
[148] P. Stewart,et al. Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. , 2010, Journal of wound care.
[149] Yanmin Hu,et al. A New Approach for the Discovery of Antibiotics by Targeting Non-Multiplying Bacteria: A Novel Topical Antibiotic for Staphylococcal Infections , 2010, PloS one.
[150] Hyun-Woo Rhee,et al. Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection , 2010, PLoS pathogens.
[151] D. Citron,et al. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. , 2010, Diagnostic microbiology and infectious disease.
[152] P. Tulkens,et al. Intra- and Extracellular Activities of Dicloxacillin against Staphylococcus aureus In Vivo and In Vitro , 2010, Antimicrobial Agents and Chemotherapy.
[153] H. Pau,et al. Intracellular Persisting Staphylococcus aureus Is the Major Pathogen in Recurrent Tonsillitis , 2010, PloS one.
[154] A. Cheung,et al. Proteolytic Regulation of Toxin-Antitoxin Systems by ClpPC in Staphylococcus aureus , 2009, Journal of bacteriology.
[155] K. Lewis,et al. Persister cells. , 2010, Annual review of microbiology.
[156] I. Chopra,et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.
[157] I. Chopra,et al. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. , 2010, The Journal of antimicrobial chemotherapy.
[158] Ronald N. Jones,et al. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. , 2009, The Journal of antimicrobial chemotherapy.
[159] P. Stewart,et al. Daptomycin Rapidly Penetrates a Staphylococcus epidermidis Biofilm , 2009, Antimicrobial Agents and Chemotherapy.
[160] H. Lilie,et al. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease , 2009, EMBO molecular medicine.
[161] Steven D. Brown,et al. Inhibitory and Bactericidal Activities of Daptomycin, Vancomycin, and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Isolates Collected from 1985 to 2007 , 2009, Antimicrobial Agents and Chemotherapy.
[162] W. Kelley,et al. Staphylococcus aureus: new evidence for intracellular persistence. , 2009, Trends in microbiology.
[163] A. Cheung,et al. Overexpression of MazFSa in Staphylococcus aureus Induces Bacteriostasis by Selectively Targeting mRNAs for Cleavage , 2009, Journal of bacteriology.
[164] S. Newsom. Ogston's coccus. , 2008, The Journal of hospital infection.
[165] Blaise R. Boles,et al. agr-Mediated Dispersal of Staphylococcus aureus Biofilms , 2008, PLoS pathogens.
[166] Timothy Foster,et al. A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived Macrophages , 2008, PloS one.
[167] J. Alder,et al. Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells , 2007, Antimicrobial Agents and Chemotherapy.
[168] J. Whitcher,et al. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. , 2007, American journal of ophthalmology.
[169] Jerome J. Schentag,et al. Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2007, Antimicrobial Agents and Chemotherapy.
[170] P. Stewart,et al. Spatial Patterns of DNA Replication, Protein Synthesis, and Oxygen Concentration within Bacterial Biofilms Reveal Diverse Physiological States , 2007, Journal of bacteriology.
[171] 杜昕,et al. Infective endocarditis , 2007 .
[172] L. Aguilar,et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. , 2006, The American journal of medicine.
[173] R. Sauermann,et al. Principles of Antibiotic Penetration into Abscess Fluid , 2006, Pharmacology.
[174] J. Hacker,et al. Global Regulatory Impact of ClpP Protease of Staphylococcus aureus on Regulons Involved in Virulence, Oxidative Stress Response, Autolysis, and DNA Repair , 2006, Journal of bacteriology.
[175] K. Rolston,et al. Vancomycin tolerance, a potential mechanism for refractory gram‐positive bacteremia observational study in patients with cancer , 2006, Cancer.
[176] G. Eliopoulos,et al. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. , 2006, The Journal of antimicrobial chemotherapy.
[177] R. Proctor,et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections , 2006, Nature Reviews Microbiology.
[178] A. Tomasz,et al. Inhibition of the Autolytic System by Vancomycin Causes Mimicry of Vancomycin-Intermediate Staphylococcus aureus-Type Resistance, Cell Concentration Dependence of the MIC, and Antibiotic Tolerance in Vancomycin-Susceptible S. aureus , 2006, Antimicrobial Agents and Chemotherapy.
[179] Ronald N. Jones. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[180] Alex van Belkum,et al. The role of nasal carriage in Staphylococcus aureus infections. , 2005, The Lancet. Infectious diseases.
[181] H. Sahl,et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics , 2005, Nature Medicine.
[182] P. François,et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. , 2005, The Journal of infectious diseases.
[183] M. Bischoff,et al. Staphylococcus aureus ClpC Is Required for Stress Resistance, Aconitase Activity, Growth Recovery, and Death , 2005, Journal of bacteriology.
[184] A. Klibanov,et al. Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. , 2005, Biotechnology and bioengineering.
[185] D. Goldmann,et al. Use of Confocal Microscopy To Analyze the Rate of Vancomycin Penetration through Staphylococcus aureus Biofilms , 2005, Antimicrobial Agents and Chemotherapy.
[186] K. Rice,et al. Acetic Acid Induces Expression of the Staphylococcus aureus cidABC and lrgAB Murein Hydrolase Regulator Operons , 2005, Journal of bacteriology.
[187] W. Goessens,et al. In vitro development and stability of tolerance to cloxacillin and vancomycin inStaphylococcus aureus , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[188] A. Tomasz,et al. Construction of a penicillin-tolerant laboratory mutant ofStaphylococcus aureus , 1986, European Journal of Clinical Microbiology.
[189] P Stoodley,et al. Survival strategies of infectious biofilms. , 2005, Trends in microbiology.
[190] W. Zimmerli,et al. Prosthetic-joint infections. , 2004, The New England journal of medicine.
[191] V. Fowler,et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. , 2004, The Journal of infectious diseases.
[192] S. Leibler,et al. Bacterial Persistence as a Phenotypic Switch , 2004, Science.
[193] P. Stoodley,et al. Detachment Characteristics and Oxacillin Resistance of Staphyloccocus aureus Biofilm Emboli in an In Vitro Catheter Infection Model , 2004, Journal of bacteriology.
[194] G. Eliopoulos,et al. Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2004, Journal of Clinical Microbiology.
[195] R. Darouiche,et al. Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.
[196] M. Krönke,et al. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. , 2004, The Journal of antimicrobial chemotherapy.
[197] K. Lewis,et al. Persister cells and tolerance to antimicrobials. , 2004, FEMS microbiology letters.
[198] C. Woods,et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. , 2003, Archives of internal medicine.
[199] Patricia F Triplett,et al. A Prospective Multicenter Study of Staphylococcus aureus Bacteremia: Incidence of Endocarditis, Risk Factors for Mortality, and Clinical Impact of Methicillin Resistance , 2003, Medicine.
[200] B. Firek,et al. The Staphylococcus aureus cidAB Operon: Evaluation of Its Role in Regulation of Murein Hydrolase Activity and Penicillin Tolerance , 2003, Journal of bacteriology.
[201] K. Lewis,et al. Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[202] Kenneth W. Bayles,et al. The Staphylococcus aureus lrgAB Operon Modulates Murein Hydrolase Activity and Penicillin Tolerance , 2000, Journal of bacteriology.
[203] A. Jones,et al. Glycopeptide tolerance in bacteria causing endocarditis. , 1999, The Journal of antimicrobial chemotherapy.
[204] A. King,et al. Glycopeptide tolerance in Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.
[205] P. Vaudaux. Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[206] R. Proctor,et al. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. , 1997, The Journal of antimicrobial chemotherapy.
[207] R. Arbeit,et al. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[208] D. Musher,et al. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. , 1994, The Journal of infectious diseases.
[209] G. Kaatz,et al. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin , 1992, Antimicrobial Agents and Chemotherapy.
[210] R. Auckenthaler,et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. , 1991, The Journal of infectious diseases.
[211] W. Goessens,et al. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis. , 1991, The Journal of infectious diseases.
[212] C. Stratton,et al. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. , 1987, The American journal of medicine.
[213] J. Costerton,et al. Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.
[214] J. Sherris. Problems in in vitro determination of antibiotic tolerance in clinical isolates , 1986, Antimicrobial Agents and Chemotherapy.
[215] A. Tomasz,et al. Antibiotic tolerance among clinical isolates of bacteria , 1986, Antimicrobial Agents and Chemotherapy.
[216] J. Rahal,et al. Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. , 1986, The American journal of medicine.
[217] W. Goessens,et al. Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice , 1984, Antimicrobial Agents and Chemotherapy.
[218] J. Sheagren. Staphylococcus aureus. The persistent pathogen (first of two parts). , 1984, The New England journal of medicine.
[219] J. Sheagren. Staphylococcus aureus. The persistent pathogen (second of two parts). , 1984, The New England journal of medicine.
[220] T. Sorrell,et al. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. , 1982, Annals of internal medicine.
[221] P. Guze,et al. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains , 1982, Antimicrobial Agents and Chemotherapy.
[222] P. Guze,et al. The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats. , 1982, The Journal of infectious diseases.
[223] M. Kalin,et al. Therapeutic failure in pneumonia caused by a tolerant strain of Staphylococcus aureus. , 1982, Scandinavian journal of infectious diseases.
[224] C. Kallick,et al. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. , 1980, Annals of internal medicine.
[225] L. Peterson,et al. Determination of tolerance to antibiotic bactericidal activity on Kirby-Bauer susceptibility plates. , 1980, American journal of clinical pathology.
[226] L. Peterson,et al. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. , 1979, Archives of internal medicine.
[227] R. Petersdorf,et al. Significance of Methicillin Tolerance in Experimental Staphylococcal Endocarditis , 1979, Antimicrobial Agents and Chemotherapy.
[228] E. Kaplan,et al. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. , 1978 .
[229] E. Dingeldein,et al. The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. , 1978, The Journal of bone and joint surgery. British volume.
[230] E. Haldane,et al. PENICILLIN-TOLERANT STAPHYLOCOCCUS AUREUS , 1977, The Lancet.
[231] M. Laverdière,et al. A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS , 1977, The Lancet.
[232] G. K. Best,et al. Evidence for Participation of Autolysins in Bactericidal Action of Oxacillin on Staphylococcus aureus , 1974, Antimicrobial Agents and Chemotherapy.
[233] R. Peters,et al. British anti-lewisite; its use and therapeutic value in arsenical intoxications. , 1947, Lancet.
[234] J. Bigger. TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION , 1944 .